Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Medicine and Dentistry
Andrographolide
22%
angiotensin[1-7]
33%
Bile Acid
36%
Biological Marker
19%
Cancer Growth Factor
12%
Cell Therapy
24%
Cholestasis
15%
Chronic Liver Disease
34%
Connective Tissue Growth Factor
25%
Cytotoxic T-Cell
11%
Diabetes
15%
Diseases
33%
Duchenne Muscular Dystrophy
44%
Fatty Acid
22%
Fatty Liver
36%
Fibroblast
13%
Fibronectin
11%
Fibrosis
66%
Heavy Meromyosin
12%
Hepatocellular Carcinoma
16%
High Fat Food
30%
Inflammation
31%
Innate Immunity
11%
Liver Cirrhosis
13%
Liver Disease
68%
Malignant Neoplasm
14%
Metabolic Dysfunction-Associated Steatotic Liver Disease
31%
Mineralocorticoid Receptor
22%
Muscle Atrophy
31%
Muscle Function
24%
Muscle Strength
46%
Muscular Dystrophy
27%
Myofibrosis
13%
NMR Spectroscopy
22%
Non-Alcoholic Fatty Liver Disease
26%
Nonalcoholic Fatty Liver
83%
Oxidative Stress
25%
Prevalence
15%
Primary Health Care
11%
Programmed Cell Death
12%
Proteasome
14%
Receptor
15%
Renin Angiotensin Aldosterone System
17%
Sarcopenia
48%
Side Effect
14%
Skeletal Muscle
100%
Somatomedin C
18%
Transforming Growth Factor Beta
43%
Triacylglycerol
12%
Ubiquitin
14%
Pharmacology, Toxicology and Pharmaceutical Science
Andrographolide
11%
Angiotensin
18%
angiotensin[1-7]
47%
Bile Acid
24%
Biological Marker
12%
Cancer Growth Factor
12%
Cholestasis
13%
Chronic Liver Disease
22%
Connective Tissue Growth Factor
22%
Dexmedetomidine
11%
Diet Induced Obesity
15%
Disease Course
12%
Diseases
24%
Duchenne Muscular Dystrophy
22%
Experimental Steatohepatitis
24%
Fatty Acid
29%
Fatty Liver
28%
Fibrosis
50%
Growth Hormone
11%
Hypoxia
22%
Inflammasome
19%
Inflammation
57%
Liver Cell Carcinoma
17%
Liver Disease
26%
Liver Fibrosis
11%
Membrane Receptor
11%
Messenger RNA
11%
Metabolic Disorder
11%
Mineralocorticoid Receptor
22%
Mouse Model
22%
Muscle Atrophy
76%
Muscle Disease
15%
Muscular Dystrophy
16%
Myosin Heavy Chain
25%
N-Acetylcysteine
15%
Nonalcoholic Fatty Liver
93%
Prostate Cancer
11%
Proteasome
16%
Reactive Oxygen Metabolite
27%
Receptor
36%
Renin
17%
Sarcopenia
37%
Sarcopenic Obesity
11%
Scavenger Receptor BI
11%
Sodium
13%
Steatosis
20%
TGF-Beta
22%
Transforming Growth Factor Beta
71%
Triacylglycerol
17%
Ubiquitin
16%
Keyphrases
Agricultural Population
11%
Angiotensin 1-7
35%
Angiotensin II Type 1 Receptor (AT1R)
12%
Atrophy
14%
Bile Acids
22%
CCN2
22%
Cholestatic Liver Disease
13%
Chronic Liver Disease
11%
Clinical Application
13%
Dietary Sodium
11%
Duchenne muscular Dystrophy
13%
Dystrophic
13%
Dystrophic muscle
12%
Fatty Acid Composition
13%
Fatty Acids
11%
Fibrosis
34%
Growth Factor Signaling
11%
Hepatic Fatty Acid Profile
11%
Liver
17%
Liver Disease
19%
Liver Disease Progression
22%
Mas Receptor
12%
Mdx Mice
22%
Mechanism of Action
11%
Membrane Receptors
11%
Mineralocorticoid Receptor
11%
Mitochondrial Dysfunction
13%
Murine Model
12%
Muscle Strength
17%
Muscular Dystrophy
12%
Non-alcoholic Fatty Liver Disease (NAFLD)
44%
Nonalcoholic Steatohepatitis
11%
NorUDCA
11%
Novel Functions
11%
Primary Care
11%
Reactive Oxygen Species
11%
Receptor Mas
11%
Renin-angiotensin System
19%
Sarcopenia
11%
Skeletal muscle
68%
Skeletal muscle Atrophy
35%
Skeletal muscle Dysfunction
14%
Steatosis
14%
Steatotic Liver Disease
11%
Tauroursodeoxycholic Acid (TUDCA)
11%
TGR5
11%
Therapeutic Strategies
11%
Transforming Growth Factor Type β
24%
Transforming Growth Factor-β
13%
Xenobiotics
11%
